# Cholinesterase inhibitors

Source: https://onco.cc/technologies/da-tech-cholinesterase-inhibitors/  
OnCo record `da-tech-cholinesterase-inhibitors` (Technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

These older medicines can support cognitive symptoms for some people. They are not disease-modifying.

## Summary

Donepezil, rivastigmine, and galantamine are the core examples. Gastrointestinal effects and slow heart rate need review.

## Fields

- Kind: Technology
- Last checked: 2026-09-21
- Tags: dementia-atlas
- Principle: Increase acetylcholine signalling at synapses.

## Sources

- NICE NG97: https://www.nice.org.uk/guidance/ng97

## Connected records

- fronts: [Symptomatic care](https://onco.cc/fronts/da-front-symptomatic-care/)
- drugs: [Donepezil](https://onco.cc/drugs/da-donepezil/), [Galantamine](https://onco.cc/drugs/da-galantamine/), [Rivastigmine](https://onco.cc/drugs/da-rivastigmine/)
- diagnoses: [Alzheimer’s disease](https://onco.cc/diagnoses/alzheimers-disease/), [Dementia with Lewy bodies](https://onco.cc/diagnoses/dementia-with-lewy-bodies/)

---
JSON: https://onco.cc/api/v1/entities/da-tech-cholinesterase-inhibitors.json